The Promise and Pitfalls of Genomics-Driven Cancer Medicine
Bibliographic Data
| ID | 15745903 |
|---|---|
| Authors | Erin Hofstatter (0000-0002-0908-8841, Yale University, corresponding author), A Bale |
| Year | 2013 |
| Volume | 15 |
| Issue | 8 |
| Pages | 681-686 |
| Publication date | 2013-08-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | The AMA Journal of Ethic (JOURNAL) |
| Journal identifiers | ISSN: 2376-6980 • E-ISSN: 2376-6980 |
| Publisher | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/virtualmentor.2013.15.8.stas1-1308 |
| PMID | 23937784 |
| OpenAlex | W161567440 |
| Language | EN |
| Citations received | 1 |
| References cited | 1 |
While next-generation genome sequencing can successfully guide cancer therapy, it can also reveal significant incidental findings that patients, families, and physicians may not be prepared to handle and may not want to know
Bioinformatics · Biology · Cancer · Cancer Medicine · Computational biology · Gene · Genome · Genomic medicine · Genomics · Pathology · Personalized medicine · Precision medicine · Cancer Genomics and Diagnostics · Genetic factors in colorectal cancer · Genomics and Rare Diseases · Medicine · Genetics · Internal Medicine
| Citations per year | 0.25 |
|---|---|
| Citation span | 2022 - 2022 (1) |
| Highly cited | No |